Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Connect with industry professionals using effective methods. Discover ways to enhance your network and open new opportunities.
16,127 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
In 2026, Interactive Brokers rolled out a major update with lower costs, broader market access, and AI-driven researc...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Sen. Ted Cruz linked a new child savings program to a broader push for Social Security reform, a move that draws shar...
Evolv Technologies stock plummeted after mixed results that still beat on revenue and nudged full-year guidance highe...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
House appropriators moved a fiscal 2027 THUD bill that preserves key housing programs but hints at reductions elsewhe...
Investors are asking if sofi stock finally bottomed? This guide breaks down the signals, what the data actually shows...
A $500 starter can set you up for long-term growth. This guide weighs the best invest $500 right now, comparing low-c...
A real-world path teaches how someone can go from homelessness to owning a seven-bedroom rental. This guide shares lo...
When a fictional character mirrors real money struggles, viewers learn practical money moves. This article uses Sydne...
A May crackdown on public-assistance fraud in Florida pushed total dubious benefits over $806,000, as authorities ann...